source
- Vertex awaits FDA decision on povetacicept for IgA nephropathy, analysts expect approvalVertex Pharmaceuticals is awaiting an FDA ruling this month on its investigational drug povetacicept, being evaluated for the treatment of IgA nephropathy. Analysts, including Myles Minter of Will…
- Zero-tolerance signs in hospitals may not curb staff violence, authors argueHospitals across the United States now display signs telling patients and visitors that abusive language, disruptive conduct, or aggression will not be tolerated and may result in removal or police…